Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | ARG2 | P78540 | 1/20 | 0.38 |
| ▸ | LIPE | Q05469 | 1/20 | 0.37 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | IDO1 | P14902 | 3/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9224156 | 0.80 | CA1 (0.61) | CA1CA2ALDH1A1TDP1IDO1 | |
| SCHEMBL3900187 | 0.77 | CA1 (0.41) | CA1CA2TSHRALDH1A1ARG2 | |
| SCHEMBL3887273 | 0.76 | TSHR (0.46) | CA1CA2TSHRALDH1A1ARG2 | |
| SCHEMBL23535576 | 0.74 | LIPE (0.39) | CA1CA2TSHRALDH1A1ARG2 | |
| SCHEMBL2836728 | 0.72 | CA1 (0.38) | CA1CA2TSHRALDH1A1ARG2 | |
| SCHEMBL8392410 | 0.72 | ALDH1A1 (0.42) | CA1CA2TSHRALDH1A1ARG2 | |
| SCHEMBL219668 | 0.72 | CA1 (0.56) | CA1CA2TSHRALDH1A1TRPA1 | |
| Pyridine SCHEMBL29132370 | 0.70 | CYP11B1 (0.36) | CA1CA2TSHRALDH1A1LIPE | |
| SCHEMBL3796769 | 0.70 | CTRB1 (0.47) | CA1CA2TSHRALDH1A1THRB | |
| SCHEMBL670441 | 0.69 | LIPE (0.35) | CA1CA2TSHRALDH1A1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111592464-A | Organic compound containing spirobifluorene structure and application thereof | 常州强力电子新材料股份有限公司 | 2020-08-28 | — | — | CN | claimed |
| CN-111592464-A | Organic compound containing spirobifluorene structure and application thereof | 常州强力电子新材料股份有限公司 | 2020-08-28 | — | — | CN | disclosed |
| US-20110282090-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | UNIVERSITE DE NICE SOPHIA ANTIPOLIS (FR) | 2011-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282090-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | ME1, MEN1, CYP2B6 | CA1 900/4885CA2 268/4885TSHR 1734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.